Elaine Greer

This inventor holds 11 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elaine Greer. Retrieved from https://idiyas.com/inventor/elaine-greer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 63(Granted Patents)

Company Filing History:

11 out of 4,488

Pfizer Corporation

patents

Years Active: 2020-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297177 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2025-05-13),

2. 12116347 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-10-15),

3. 11905255 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-02-20),

4. 11884635 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-01-30),

5. 11884634 - Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide (2024-01-30),

6. 11845732 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-12-19),

7. 11820748 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-11-21),

8. 11566006 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-01-31),

9. 10941118 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2021-03-09),

10. 10710966 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2020-07-14),

11. 10590087 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2020-03-17),

Title: Elaine Greer: Innovator in Pharmaceutical Developments

Introduction

Elaine Greer, based in Groton, CT, is a prominent inventor in the field of pharmaceuticals, boasting a remarkable total of 11 patents. Her innovative contributions continue to advance medical science, particularly in the area of cancer treatment.

Latest Patents

Among her most recent patents is the discovery of solid-state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide. This patent details several key aspects, including:

a) Solid-state forms of hydrobromide salts of the compound;

b) Pharmaceutical compositions that incorporate one or more solid-state forms of these hydrobromide salts, possibly alongside a pharmaceutically acceptable carrier;

c) Methods for treating tumors or cancers through the administration of these solid-state forms to subjects requiring treatment;

d) Procedures for preparing these solid-state forms effectively.

Career Highlights

Elaine is an essential member of Pfizer Corporation, where her work is integral to the development of innovative pharmaceutical solutions. Her dedication to research and development emphasizes her commitment to enhancing treatment options available in the market.

Collaborations

Throughout her career, Elaine has collaborated with esteemed colleagues like Stephen Anderson and Mark Maloney, further driving innovation in the pharmaceutical domain. These collaborations highlight the importance of teamwork in achieving groundbreaking advancements.

Conclusion

With a portfolio that includes 11 patents and innovative approaches to treating serious medical conditions, Elaine Greer exemplifies the spirit of invention. Her work is making a significant impact in the pharmaceutical industry, particularly in the quest for effective cancer therapies.

Profile summary based on public USPTO records.